GlassScriptPhysician profile
Mohammed Shahid
NPI 1508106345
$1,567.90
in general payments reported to CMS, 2019-2025
18 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $135 · 2021: $74.01 · 2022: $398 · 2023: $264 · 2024: $101 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $506.83 | 2019-2023 | Ortholoc 2 Lapifuse, Viaflow, Prophecy |
| Abbott Laboratories | $302.60 | 2022-2024 | Proclaim |
| Paragon 28, INC. | $150.69 | 2019-2023 | Additive Orthopedics |
| Smith+Nephew, INC. | $116.87 | 2019-2023 | Regranex, Collagenase Santyl |
| Assertio Therapeutics, INC. | $101.23 | 2019-2020 | |
| Ortho Solutions INC | $96.72 | 2025 | |
| Reflow Medical INC | $75.00 | 2025 | |
| Bioventus LLC | $36.91 | 2019-2022 | |
| Averitas Pharma INC. | $32.07 | 2023 | Qutenza |
| Pfizer INC. | $24.72 | 2019 | |
| Amniox Medical, INC. | $21.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.61 | 2022 | |
| Hikma Pharmaceuticals USA | $16.43 | 2019 | |
| Sebela Pharmaceuticals INC. | $16.43 | 2019 | |
| Cashflow Solutions, LLC | $15.31 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $13.18 | 2022 | |
| Zimmer Biomet Holdings, INC. | $12.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Shahid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.